ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
94.08
-0.32 (-0.34%)
At close: 4:00PM EDT

94.08 0.00 (0.00%)
After hours: 5:35PM EDT

Stock chart is not supported by your current browser
Previous Close94.40
Open94.39
Bid84.50 x 3100
Ask95.65 x 1100
Day's Range92.42 - 94.51
52 Week Range55.80 - 96.45
Volume5,182,385
Avg. Volume4,226,157
Market Cap52.884B
Beta1.20
PE Ratio (TTM)11.46
EPS (TTM)8.21
Earnings DateOct 22, 2018 - Oct 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2003-11-12
1y Target Est88.29
Trade prices are not sourced from all markets
  • Reutersyesterday

    Gilead to launch generic versions of its hepatitis drugs

    Gilead Sciences Inc said on Monday it plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare costs. Gilead's decision comes more than a month after the U.S. Food and Drug Administration approved Teva Pharmaceutical Industries Ltd's copycat version of Mylan NV's life-saving allergy injection, EpiPen. Gilead said the low-cost variants of the drugs will be available at a list price of $24,000 for the most common course of therapy from January.

  • Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate
    Bloombergyesterday

    Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate

    Gilead Sciences Inc. will sell cheaper versions of its blockbuster hepatitis C drugs, the original versions of which sparked widespread debate about U.S. pharmaceutical costs when they were introduced at a price of more than $1,000 a pill. The new, cheaper versions of Gilead’s Epclusa and Harvoni will cost $24,000 for a course of treatment, the Foster City, California-based company said in a statement on Monday. When Harvoni came on the market in 2014, Gilead set a list price of $94,500.

  • Moody's4 days ago

    Halfmoon Parent, Inc. -- Moody's assigns a P-2 commercial paper rating to Halfmoon Parent, Inc.

    Rating Action: Moody's assigns a P-2 commercial paper rating to Halfmoon Parent, Inc. New York, September 21, 2018 -- Moody's Investors Service (Moody's) has assigned a Prime-2 short term rating, on review for downgrade, to the commercial paper (CP) program of Halfmoon Parent, Inc. (Halfmoon), a wholly owned subsidiary of Cigna Corporation (Cigna, Baa1 on review for downgrade). This is consistent with Moody's rating of Cigna's short-term commercial paper.

  • PR Newswire6 days ago

    Express Scripts Earns Highest Overall Customer Satisfaction Rating According to Independent Survey of Plan Sponsors

    The Pharmacy Benefit Management Institute (PBMI) 2018 survey ranks Express Scripts at the top of pharmacy benefit managers (PBMs) in overall satisfaction ST. LOUIS , Sept. 19, 2018 /PRNewswire/ -- According ...

  • Department of Justice Approves Cigna-Express Scripts Deal
    GuruFocus.com7 days ago

    Department of Justice Approves Cigna-Express Scripts Deal

    Clearing a major hurdle in the health care space's path to consolidation, Cigna Corp. (CI) announced on Monday its $52 billion acquisition of Express Scripts Holding Co. (ESRX) was approved by the U.S. Department of Justice, sending shares higher in after-hours trading. Warning! GuruFocus has detected 3 Warning Signs with AVGO. By combining the Bloomfield, Connecticut-based health insurer and the St. Louis-based pharmacy benefits manager, Tim Wentworth, president and CEO of Express Scripts, said the companies hope to "transform" health care by reducing costs, expanding choice and improving patient outcomes.

  • Cigna Moves Closer to Express Scripts Buyout With DoJ Nod
    Zacks7 days ago

    Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

    Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit7 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    Express Scripts Holding Co NASDAQ/NGS:ESRX

  • The Wall Street Journal7 days ago

    [$$] Stocks to Watch: FedEx, Oracle, Avon, Express Scripts

    The market reacts to quarterly results from FedEx and Oracle, as well as a takeover overture for Avon.

  • Reuters8 days ago

    PRESS DIGEST -Wall Street Journal - Sept 18

    The following are the top stories in the Wall Street Journal. - Apple Inc dodged stinging duties on its smartwatches and wireless earbuds after the U.S. excluded those gadgets from tariffs on $200 billion in Chinese goods, though the tech giant still faces retaliatory measures being weighed by China that could strike iPhone production there. - SpaceX's first paying passenger will be Japanese billionaire Yusaku Maezawa, who is to blast off from earth in 2023, circle the moon and return, the company's founder and chief executive, Elon Musk, said at an event Monday evening.

  • Cigna deal gets antitrust nod, positive sign for CVS/Aetna
    Reuters8 days ago

    Cigna deal gets antitrust nod, positive sign for CVS/Aetna

    The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.

  • Cigna deal gets antitrust nod, positive sign for CVS/Aetna
    Reuters8 days ago

    Cigna deal gets antitrust nod, positive sign for CVS/Aetna

    The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.

  • Cigna deal gets antitrust nod, positive sign for CVS-Aetna
    Reuters8 days ago

    Cigna deal gets antitrust nod, positive sign for CVS-Aetna

    The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.

  • Congratulations, Cigna! Now Comes the Hard Part.
    Bloomberg8 days ago

    Congratulations, Cigna! Now Comes the Hard Part.

    Cigna Corp. has successfully dodged two giant obstacles in its attempt to purchase pharmacy-benefit manager Express Scripts Holding Co. First, it got past Carl Icahn, who tried to convince investors to vote no on the deal in August, only to drop the effort days later after giving it further thought.

  • Cigna-Express Scripts Deal Is Cleared by U.S. Justice Department
    Bloomberg8 days ago

    Cigna-Express Scripts Deal Is Cleared by U.S. Justice Department

    Antitrust enforcers signed off on Cigna Corp.’s $54 billion takeover of pharmacy-benefit manager Express Scripts Holding Co., clearing one of two health-care deals that stand to reshape the industry. Approval by the Justice Department smooths the way for the deal to wrap up by the end of the year, the companies said Monday in a joint statement. Express Scripts shares rose 3.7 percent to $95.23 at the close in New York.

  • CNBC8 days ago

    DOJ clears Cigna's acquisition of Express Scripts

    The U.S. Department of Justice has cleared Cigna's acquisition of Express Scripts, the companies announced in a statement Monday. Shareholders voted to approve the merger last month, despite opposition from activist investor Carl Icahn. The U.S. Department of Justice has cleared Cigna CI 's $52 billion acquisition of Express Scripts ESRX , the companies announced in a statement Monday.

  • PR Newswire13 days ago

    Express Scripts Implements Emergency Procedures for Affected Members in Advance of Hurricane Florence

    ST. LOUIS, Sept. 12, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Florence, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies. In accordance with State of Emergency declarations in South Carolina, North Carolina, Virginia, Maryland, and the District of Columbia, Express Scripts (ESRX) has implemented emergency procedures for its members in these areas, including Medicare, Medicaid and TRICARE® beneficiaries, and patients who fill medications via the company's Accredo specialty pharmacy.

  • Why Express Scripts Gained 11% in August
    Motley Fool15 days ago

    Why Express Scripts Gained 11% in August

    Second-quarter results were strong enough to lift the company's sales outlook last month.

  • Moody's19 days ago

    Express Scripts Holding Company -- Moody's changes direction of Express Scripts rating review from uncertain to downgrade

    Moody's Investors Service ("Moody's") changed the direction of its rating review of the senior unsecured debt of Express Scripts Holding Company ("Express Scripts") from review direction uncertain to review for downgrade. Moody's placed Express Scripts' Baa2 senior unsecured ratings under review with direction uncertain on March 9, 2018 following the announcement that Cigna Corporation ("Cigna") reached a definitive agreement to acquire Express Scripts in a transaction valued at approximately $67 billion.

  • Investor's Business Daily19 days ago

    IBD Stock Of The Day: This Health Leader Hits Buy Point After Tight Trading

    Anthem stock is surging from buy zone after several weeks of tight trading. As IBD founder William J. O'Neil mused, constructive patterns often have periods of tight trading.

  • WellCare in talks to buy some CVS-Aetna assets, Wall Street Journal reports
    American City Business Journals19 days ago

    WellCare in talks to buy some CVS-Aetna assets, Wall Street Journal reports

    The report comes on the heels of the Tampa managed health care provider wrapping up the largest deal in its history.

  • Cigna Is Selling Bonds to Finance Express Scripts Deal
    Bloomberg19 days ago

    Cigna Is Selling Bonds to Finance Express Scripts Deal

    Cigna Corp. sold $20 billion of bonds to fund its takeover of Express Scripts Holding Co., making for the U.S. corporate-bond market’s second-biggest of the year. The health insurer issued senior unsecured bonds in 10 parts, according to a person with knowledge of the matter. The longest portion of the offering, a $3 billion security maturing in 2048, yields 1.87 percentage points above Treasuries, after initially discussing around 2.05 percentage points, said the person, who asked not to be identified because talks with potential investors are private.

  • The Wall Street Journal20 days ago

    [$$] Justice Department Nearing Antitrust Approval of Health Mergers Combining CVS-Aetna, Cigna-Express Scripts

    WASHINGTON—Justice Department antitrust enforcers are preparing to give the green light to two deals in the health-care industry, CVS Health Corp.’s planned acquisition of health insurer Aetna Inc. and Cigna Corp.’s planned purchase of Express Scripts Holding Co., according to people familiar with the matter. Both deals could receive formal antitrust approval as soon as the next few weeks, these people said. The Justice Department has identified some competition concerns surrounding the nearly $70 billion CVS-Aetna deal, and the companies will be required to sell off assets related to Medicare drug coverage to resolve those issues, some of the people familiar with the matter said.

  • Bloomberg20 days ago

    Major Health-Industry Deals Move Closer to Approval

    The U.S. Department of Justice is on track to soon approve the acquisition of pharmacy-benefit manager Express Scripts Holding Co. by health insurer Cigna Corp., as well as CVS Health Corp.’s takeover of insurer Aetna Inc., said the person, who asked not to be identified because the process is private. CVS and Aetna are in talks with the Justice Department about divesting Medicare prescription drug plans to resolve the government’s concerns the deal will otherwise harm competition. “We continue to constructively work with the Department of Justice and remain confident the deal will close by the end of the year,” said Brian Henry, a spokesman for Express Scripts.

  • CNBC20 days ago

    Justice Department reportedly close to approving CVS-Aetna, Cigna-Express Scripts deals

    The Department of Justice is close to approving CVS Health's acquisition of Aetna and Cigna's acquisition of Express Scripts, The Wall Street Journal reported Wednesday, citing people familiar with the matter.